Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.verified

KYTX

Price:

$2.55

Market Cap:

$110.21M

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of patients with lupus nephritis and systemic sclerosis that is in Phase I clinical trial; and for myasthenia gravis and multiple sclerosis that is in Phase II clinical trial. The company is also developing KYV-201, an allogeneic CD19 CAR T-cell product candidate that is in preclinical stage to treat multiple autoimmune diseases. In addition, it is developing product candidates to treat other autoimmune diseases, such as inflammatory...[Read more]

Industry

Biotechnology

IPO Date

2024-02-09

Stock Exchange

NASDAQ

Ticker

KYTX

The ROE as of July 2025 (TTM) for Kyverna Therapeutics, Inc. (KYTX) is -51.62%

According to Kyverna Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -51.62%. This represents a change of 282.25% compared to the average of -13.50% of the last 4 quarters.

Kyverna Therapeutics, Inc. (KYTX) Historical ROE (quarterly & annually)

How has KYTX ROE performed in the past?

The mean historical ROE of Kyverna Therapeutics, Inc. over the last ten years is -18.64%. The current -51.62% ROE has changed 176.95% with respect to the historical average. Over the past ten years (40 quarters), KYTX's ROE was at its highest in in the December 2023 quarter at 15.73%. The ROE was at its lowest in in the March 2023 quarter at -23.87%.

Quarterly (TTM)
Annual

Average

-18.64%

Median

-4.39%

Minimum

-122.75%

Maximum

56.97%

Kyverna Therapeutics, Inc. (KYTX) ROE by Quarter and Year

Discovering the peaks and valleys of Kyverna Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 56.97%

Minimum Annual Increase = -414.38%

Minimum Annual ROE = -122.75%

Quarterly (TTM)
Annual
YearROEChange
2024-47.82%-61.05%
2023-122.75%-414.38%
202239.05%-31.46%

Kyverna Therapeutics, Inc. (KYTX) Average ROE

How has KYTX ROE performed in the past?

The current ROE of Kyverna Therapeutics, Inc. (KYTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-43.84%

5-year avg

-18.64%

10-year avg

-18.64%

Kyverna Therapeutics, Inc. (KYTX) ROE vs. Peers

How is KYTX’s ROE compared to its peers?

Kyverna Therapeutics, Inc.’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Kyverna Therapeutics, Inc. (KYTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kyverna Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kyverna Therapeutics, Inc. (KYTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kyverna Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Kyverna Therapeutics, Inc.'s ROE?

How is the ROE calculated for Kyverna Therapeutics, Inc. (KYTX)?

What is the highest ROE for Kyverna Therapeutics, Inc. (KYTX)?

What is the 3-year average ROE for Kyverna Therapeutics, Inc. (KYTX)?

What is the 5-year average ROE for Kyverna Therapeutics, Inc. (KYTX)?

How does the current ROE for Kyverna Therapeutics, Inc. (KYTX) compare to its historical average?